ResMed Inc.
RSMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $37,852,728 | $27,484,106 | $32,068,153 | $30,619,816 |
| - Cash | $1,209,450 | $238,361 | $227,891 | $273,710 |
| + Debt | $851,813 | $873,935 | $1,579,908 | $917,550 |
| Enterprise Value | $37,495,091 | $28,119,680 | $33,420,170 | $31,263,656 |
| Revenue | $5,146,327 | $4,685,297 | $4,222,993 | $3,578,127 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Gross Profit | $3,054,970 | $2,655,303 | $2,355,662 | $2,024,311 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| EBITDA | $1,913,377 | $1,533,543 | $1,358,801 | $1,176,636 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |
| Net Income | $1,400,723 | $1,020,951 | $897,556 | $779,437 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| % Growth | 37.4% | 13.6% | 14.9% | – |
| Operating Cash Flow | $1,751,588 | $1,401,260 | $693,299 | $351,147 |
| Capital Expenditures | -$89,865 | -$114,856 | -$134,000 | -$156,036 |
| Free Cash Flow | $1,661,723 | $1,286,404 | $559,299 | $195,111 |